TYPE-2 DIABETES - PRIMARY VASCULAR DISORDER WITH METABOLIC SYMPTOMS

被引：4
|
作者：
GANROT, PO [1 ]
CURMAN, B [1 ]
KRON, B [1 ]
机构：
[1] OREBRO MED CTR HOSP,DEPT INTERNAL MED,S-70185 OREBRO,SWEDEN
来源：
MEDICAL HYPOTHESES | 1987年 / 24卷 / 01期
关键词：
D O I：
10.1016/0306-9877(87)90049-1
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：77 / 86
页数：10
相关论文
共 50 条
  • [1] SYMPTOMS AT DIAGNOSIS OF TYPE-2 DIABETES
    FOGSTROM, BM
    EKSTRAND, A
    GROOP, PH
    GROOP, L
    [J]. ACTA ENDOCRINOLOGICA, 1985, 110 : U30 - U30
  • [2] Metabolic surgery to prevent type-2 diabetes
    Rudofsky, G.
    Vogelbach, P.
    [J]. DIABETOLOGE, 2017, 13 (06): : 403 - 407
  • [3] Compliance with the metabolic control objectives in patients with type-2 diabetes attended in primary care
    Sandin-Vazquez, Maria
    Sarria-Santamera, Antonio
    [J]. ATENCION PRIMARIA, 2008, 40 (04): : 211 - 213
  • [4] Metabolic flux in macrophages in obesity and type-2 diabetes
    Wong, Angela
    Sun, Qiuyu
    Latif, Ismail Ibrahim
    Karwi, Qutuba G.
    [J]. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2024, 27
  • [5] Metabolic syndrome in subjects with type-2 diabetes mellitus
    Alebiosu, CO
    Odusan, BA
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2004, 96 (06) : 817 - 821
  • [6] Impact of Metabolic Surgery on Type-2 Diabetes Remission
    Baiocchi, Cejana de Abrantes Figueiredo
    de Sa, Diana Aristotelis Rocha
    [J]. CURRENT DIABETES REVIEWS, 2021, 17 (07)
  • [7] Primary prevention of type-2 diabetes in developing countries
    Dagogo-Jack, S
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (03) : 415 - 419
  • [8] Autophagy, a relevant process for metabolic health and type-2 diabetes
    Macho-Gonzalez, Adrian
    Sesmero, Jose Manuel Martinez
    Sanchez-Muniz, Francisco J.
    [J]. NUTRICION HOSPITALARIA, 2023, 40 (02) : 457 - 464
  • [9] Is Type 2 Diabetes a Primary Mitochondrial Disorder?
    Weksler-Zangen, Sarah
    [J]. CELLS, 2022, 11 (10)
  • [10] METABOLIC EFFECTS OF GLIBENCLAMIDE AND GLIPIZIDE IN PATIENTS WITH TYPE-2 DIABETES
    GROOP, PH
    GROOP, L
    TOTTERMAN, KJ
    PELKONEN, R
    [J]. ACTA ENDOCRINOLOGICA, 1982, 100 : 25 - 25
12345